SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dave who wrote (283)9/11/2002 3:08:07 AM
From: Dave   of 370
 
On July 17, VION issued a press release stating that the company has until October 1 to get its stock price up to $1/share and keep it there for 10 consecutive trading days, or it will be delisted from Nasdaq. It looked for a while like somebody was desperately trying to bid up the stock because it was pressing strongly upward in the face of a declining market. If that's the case, that somebody must have blown a lot of cash (relative to the size of the company). Doesn't look likely that they'll succeed.

Is there any chance, given the near certainty of delisting, that VION will still find enough funding to survive until some semblance of profitability? I would hazard a guess that if they do manage to find this funding, it will be in the form of a loan with onerous, usurious terms.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News